What is the threat from extended spectrum β-lactamase-producing organisms in children?

Archives of Disease in Childhood

Volumn 96, Issue 4, 2011, Pages 325-327

  Hague, Rosie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; MONOBACTAM DERIVATIVE; SULBACTAM;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CHILD; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; SERRATIA; STAPHYLOCOCCUS;

BACTERIA; BETA-LACTAMASES; CHILD; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; RISK FACTORS;

EID: 79953207731     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.184911     Document Type: Review

References (31)

1. Hall BG, Barlow M. Evolution of the serine beta-lactamases: past, present and future. Drug Resist Updat 2004;7:111-23. (Pubitemid 38736064)
2. Mims C, Dockerell H, Goering RV, et al. Attacking the Enemy: Antimicrobial Agents and Chemotherapy in Medical Microbiology. London: Elsevier,2008:479-518.
3. Knothe H, Shah P, Krcmery V, et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates ot Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315-17. (Pubitemid 14213754)
4. Quinn JP, Miyashiro D, Sahm D, et al. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989;33:1451-6. (Pubitemid 19227994)
5. Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med 2005;352:380-91.
6. Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008;57:1247-50.
7. Weill FX, Demartin M, Tandé D, et al. SHV-12-like extended-spectrum-beta-lactamase-producing strains of Salmonella enterica serotypes Babelsberg and Enteritidis isolated in France among infants adopted from Mali. J Clin Mcrobiol 2004;42:2432-7. (Pubitemid 38747485)
8. Tristram SG, Pitout MJ, Forward K, et al. Characterization of extended-spectrum beta-lactamase-producing isolates of Haemophilus parainfluenzae. J Antimicrob Chemother 2008;61:509-14. (Pubitemid 351321122)
9. Health Protection Agency. Antimicrobial Resistance and Prescribing in England, Wales and Northern Ireland 2008. London. Health Protection Agency 2008.
10. European Antimicrobial Resistance Surveillance System. http://www.rivm.nl/earss/database (accessed 28 August 2010).
11. Kim YK, Pai H, Lee HJ, et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002;46:1481-91. (Pubitemid 34415332)
12. Gales AC, BolmströmA, Sampaio J, et al. Antimicrobial susceptibility of Klebsiella pneumoniae producing extended-spectrum beta-lactamase (ESBL) Isolated in Hospitals in Brazil. Braz J Infect Dis 1997;1:196-203.
13. Boo NY, Ng SF, Lim VK. A case-control study of riskfactors associated with rectal colonization of extended-spectrum beta-lactamase producing Klebsiella sp. in newborn infants. J Hosp Infect 2005;61:68-74. (Pubitemid 41070276)
14. Boszczowski I, Nicoletti C, Puccini DM, et al. Outbreak of extended spectrum beta-lactamase-producing Klebsiella pneumoniae infection in a neonatal intensive care unit related to onychomycosis in a health care worker. Pediatr Infect Dis J 2005;24:648-50. (Pubitemid 40993625)
15. López-Cerero L, De Cueto M, Saenz C, et al. Neonatal sepsis caused by a CTX-M-32-producing Escherichia coli isolate. J Med Microbiol 2008;57:1303-5.
16. Caubilla-Barron J, Hurrell E, Townsend S, et al. Genotypic and phenotypic analysis of Enterobacter sakazakii strains from an outbreak resulting in fatalities in a neonatal intensive care unit in France. J Clin Microbiol 2007;45:3979-85. (Pubitemid 350274880)
17. Mel E, Nahum E, Lowenthal A, et al. Extended spectrum beta-lactamase-positive Escherichia coli bacteremia complicating rotavirus gastroenteritis. Pediatr Infect Dis J 2006;25:962. (Pubitemid 44510605)
18. Tandé D, Jallot N, Bougoudogo F, et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Malian orphanage. Emerging Infect Dis 2009;15:472-4.
19. Bagattini M, Crivaro V, Di Popolo A, et al. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Antimicrob Chemother 2006;57:979-82.
20. Le J, Nguyen T, Okamoto M, et al. Impact of empiric antibiotic use on development of infections caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit. Pediatr Infect Dis J 2008;27:314-18. (Pubitemid 351483065)
21. Cassettari VC, da Silveira IR, Dropa M, et al. Risk factors for colonisation of newborn infants during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit. J Hosp Infect 2009;71:340-7.
22. Peńa C, Pujol M, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998;42:53-8. (Pubitemid 28053326)
23. Zaoutis TE, Goyal M, Chu JH, et al. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics 2005;115:942-9.
24. Raymond J, Nordmann P, Doit C, et al. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study. Pediatrics 2007;119:e798-803.
25. Cheng CH, Tsai MH, Huang YC, et al. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Pediatrics 2008;122:1212-17.
26. Conterno LO, Shymanski J, Ramotar K, et al. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum beta-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect 2007;65:354-60. (Pubitemid 46477974)
27. Marwick C, Davey P. Care bundles: the holy grail of infectious risk management in hospital? Curr Opin Infect Dis 2009;22:364-9.
28. Kola A, Holst M, Chaberny IF, et al. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect 2007;66:46-51. (Pubitemid 46657123)
29. Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol 2004;25:838-41. (Pubitemid 40036759)
30. Lee J, Pai H, Kim YK, et al. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 2007;60:629-37. (Pubitemid 47299880)
31. Health Protection Scotland. Carbapenamase producing Enterobacteriaceae in the UK. HPS Wkly Rep 2009;43; ISSN 1753-4224 (online).